相对端粒长度与前列腺癌死亡率的关系
研究纳入533例接受放疗前的前列腺癌患者,采用定量PCR法检测外周血白细胞相对端粒长度(RTL),中位随访149个月。多因素Cox回归显示,较长的RTL四分位与更高的全因死亡率独立相关(HR=1.22,95%CI:1.07-1.39,p=0.003)。
要点
- 白细胞相对端粒长度较长与前列腺癌患者全因死亡率升高相关。
- 该关联在调整年龄、雄激素剥夺治疗和风险分组后仍显著。
- RTL或可作为前列腺癌长期预后的潜在生物标志物。
核心结论
- 较长的白细胞相对端粒长度预测前列腺癌患者更高的全因死亡率。
研究设计与样本
- 研究纳入533例前列腺癌患者,在放疗开始前采集血样,采用定量聚合酶链反应法测定外周血白细胞相对端粒长度,主要结局为全因死亡率。
主要发现
- 中位随访149个月期间,188例(35.3%)患者死亡。
- 单因素Cox回归中,RTL四分位(较长RTL)与更高的全因死亡率显著相关(HR=1.20;95%CI:1.05-1.36;p=0.006)。
- 多因素Cox回归模型纳入诊断时年龄、雄激素剥夺治疗和风险分组(基于PSA水平、Gleason评分和T分期)后,RTL四分位仍为更高全因死亡率的显著预测因子(HR=1.22;95%CI:1.07-1.39;p=0.003)。
临床怎么用
- 在前列腺癌患者中,可考虑检测白细胞相对端粒长度以辅助长期预后评估。
- 较长RTL提示更高的全因死亡风险,或可支持更密切的随访策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Telomeres are essential for the maintenance of chromosomal integrity and telomere length has been associated with cancer risk and development. Aim of the present study was to analyze the prognostic value of leukocyte relative telomere (RTL) length in long-term prostate cancer (PCa) mortality. METHODS: Blood samples of PCa patients were obtained before initiation of radiotherapy. RTL of peripheral blood leukocytes was determined by a quantitative polymerase chain reaction method in 533 patients with PCa. Main outcome was overall mortality. RESULTS: During a median follow-up time of 149 months, 188 (35.3%) patients died. In a univariate Cox regression analysis, RTL quartiles (longer RTL) were significantly associated with higher overall mortality (hazard ration (HR) = 1.20; 95% confidence interval (CI): 1.05-1.36; p = 0.006). In a multivariate Cox regression model including age at diagnosis, androgen deprivation therapy, and risk group (based on PSA level, GS, and T stage), RTL quartiles remained a significant predictor of higher overall mortality (HR = 1.22; 95% CI: 1.07-1.39; p = 0.003). CONCLUSIONS: Longer leukocyte RTL predicts higher overall mortality in patients with PCa.
引用
- Renner W, Krenn-Pilko S, Gruber HJ, et al. Relative telomere length and prostate cancer mortality. Prostate Cancer Prostatic Dis. 2018. PMID: 30082901. doi:10.1038/s41391-018-0068-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。